NATURAL CELL-MEDIATED RESISTANCE IN CRYPTOCOCCOSIS
隐球菌病中自然细胞介导的耐药性
基本信息
- 批准号:3480986
- 负责人:
- 金额:$ 21.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-01-01 至 1996-06-30
- 项目状态:已结题
- 来源:
- 关键词:CD antigens Cryptococcus neoformans T lymphocyte biological signal transduction cell adhesion molecules cellular immunity colony stimulating factor cryptococcosis enzyme linked immunosorbent assay host organism interaction human tissue in situ hybridization interferons interleukin 2 interleukin 3 laboratory mouse leukocyte activation /transformation messenger RNA natural killer cells tissue /cell culture tumor necrosis factor alpha tumor necrosis factor beta
项目摘要
Cryptococcosis ranks fourth in life-threatening infections in patients
with acquired immune deficiency syndrome (AIDS, and the disease is a
frequent and serious problem in individuals with compromised cell-
mediated immune responses. Although it is well established that CD4
lymphocyte-dependent immune responses are essential for protection
against Cryptococcus neoformans, natural effecotr cells make significant
contributions to effective first-line host defense and, via activation
by cytokines produced by immune T cells, may also function as effectors
of acquired immunity. We have previously demonstrated that murine NK
cells directly interact in vitro with C. neoformans and damage the
organism. In addition, we and others have shown that NK cells
participate in clearance of ryptococci from infected tissues. We now
propose to extend our investigations of murine NK cells to determine if
these cells also inhibit C. neoformans indirectly by secreting cytokines
which potentiate the anti-cryptococcal activity of phagocytic natural
effector cells. Culture supernatants from NK cells incubated with C.
neoformans will be assayed for tumor necrosis factor, gamma interferon
and colony stimulating factors by functional bioassays and ELISA, and
induction of cytokines in NK cells will be confirmed by demonstrating
cytokine specific messenger RNA using in situ hybridization. Cytokine
containing supernatants from C. neoformans-stimulated NK cells and, for
comparison, recombinant cytokines will be assessed for their abilities
to activate polymorphonuclear leukocytes and macrophages to more
effectively kill cryptoccocci.
Although the functional activity of murine and human NK cells are
similar, these two populations of cells recognize different tumor cell
targets. Studies are proposed, therefore, to examine the
anticryptococcal activity of NK cells from healthy human donors. In our
preliminary studies, human peripheral blood NK cells, as well as T
cells, attached to and damaged cryptococcal cells. We propose to define
the ultrastructural and phenotypic characteristics of the human
peripheral blood lymphocytes which interact with C. neoformans and
compare and contrast the two different populations of human effector
cells with regard to the requirements for cryptococcal cell
interactions. In addition, we will determine if lymphokine-activated NK
cells display greater direct anticryptococcal activity than do freshly
isolated NK cells and if human NK cells have the capability to
participate indirectly via cytokine production to enhance the
anticryptococcal activity of other natural effector cells. Considering
the potential role of NK cells in host defense in cryptococcosis, it is
important to dissect the mechanisms by which mouse and human NK cells
restrict C. neoformans growth and to delineate the immunomodulatory
cytokines which may be involved in NK cell-mediated anticryptococcal
resistance.
隐球菌病在危及患者生命的感染中排名第四
患有获得性免疫缺陷综合征(艾滋病),这种疾病是一种
细胞受损的个体经常出现严重的问题-
介导的免疫反应。尽管已经很好地确定了CD4
淋巴细胞依赖的免疫反应对于保护是必不可少的
对于新生隐球菌,自然效应细胞具有显著的作用
为有效的一线宿主防御做出贡献,并通过激活
通过免疫T细胞产生的细胞因子,也可能发挥效应器的作用
获得性豁免权。我们之前已经证明了小鼠NK细胞
细胞在体外直接与新生芽孢杆菌相互作用并损伤
有机体。此外,我们和其他人已经表明,NK细胞
参与清除感染组织中的隐球菌。我们现在
建议扩大我们对小鼠NK细胞的研究,以确定
这些细胞还通过分泌细胞因子间接抑制新生葡萄球菌。
它们增强了天然吞噬细胞的抗隐球菌活性
效应细胞。NK细胞培养上清与C.
将对新生杆菌进行肿瘤坏死因子、γ干扰素检测
和集落刺激因子通过功能生物测定和酶联免疫吸附试验,以及
NK细胞中细胞因子的诱导将通过演示得到证实
应用原位杂交技术检测细胞因子特异性信使RNA。细胞因子
含有新生芽孢杆菌刺激的NK细胞的上清液,
相比之下,重组细胞因子将被评估其能力
激活多形核白细胞和巨噬细胞
有效地杀死了隐球菌。
虽然小鼠和人NK细胞的功能活性
相似的是,这两类细胞识别不同的肿瘤细胞
目标。因此,建议进行研究,以检查
健康献血者NK细胞的抗隐球菌活性。在我们的
初步研究,人外周血中NK细胞以及T细胞
细胞,附着在和损坏的隐球菌细胞。我们建议定义
人的超微结构和表型特征
外周血淋巴细胞与新生葡萄球菌和
比较和对比两种不同人群的人体效应器
关于隐球菌细胞的要求
互动。此外,我们将确定淋巴因子激活的NK细胞
细胞表现出比新鲜细胞更强的直接抗隐球菌活性
分离的NK细胞和人类NK细胞是否有能力
通过细胞因子的产生间接参与促进
其他天然效应细胞的抗隐球菌活性。考虑
NK细胞在隐球菌病宿主防御中的潜在作用
重要的是要剖析小鼠和人类NK细胞的机制
抑制新生葡萄球菌生长及其免疫调节作用的研究
NK细胞介导的抗隐球菌病可能涉及的细胞因子
抵抗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JUNEANN W MURPHY其他文献
JUNEANN W MURPHY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JUNEANN W MURPHY', 18)}}的其他基金
EST ANALYSIS OF A BASIDIOMYCETE CRYPTOCOCCUS NEOFORMANS
担子菌新型隐球菌的EST分析
- 批准号:
6374446 - 财政年份:2000
- 资助金额:
$ 21.24万 - 项目类别:
EST ANALYSIS OF A BASIDIOMYCETE CRYPTOCOCCUS NEOFORMANS
担子菌新型隐球菌的EST分析
- 批准号:
6511225 - 财政年份:2000
- 资助金额:
$ 21.24万 - 项目类别:
EST ANALYSIS OF A BASIDIOMYCETE CRYPTOCOCCUS NEOFORMANS
担子菌新型隐球菌的EST分析
- 批准号:
6202798 - 财政年份:2000
- 资助金额:
$ 21.24万 - 项目类别:
IMMUNOMODULATION DURING PULMONARY CRYPTOCOCCOSIS
肺隐球菌病期间的免疫调节
- 批准号:
6184390 - 财政年份:1997
- 资助金额:
$ 21.24万 - 项目类别:
IMMUNOMODULATION DURING PULMONARY CRYPTOCOCCOSIS
肺隐球菌病期间的免疫调节
- 批准号:
6056513 - 财政年份:1997
- 资助金额:
$ 21.24万 - 项目类别:
IMMUNOMODULATION DURING PULMONARY CRYPTOCOCCOSIS
肺隐球菌病期间的免疫调节
- 批准号:
2771665 - 财政年份:1997
- 资助金额:
$ 21.24万 - 项目类别:
IMMUNOMODULATION DURING PULMONARY CRYPTOCOCCOSIS
肺隐球菌病期间的免疫调节
- 批准号:
6389843 - 财政年份:1997
- 资助金额:
$ 21.24万 - 项目类别:
IMMUNOMODULATION DURING PULMONARY CRYPTOCOCCOSIS
肺隐球菌病期间的免疫调节
- 批准号:
2542779 - 财政年份:1997
- 资助金额:
$ 21.24万 - 项目类别:
NATURAL CELL-MEDIATED RESISTANCE IN CRYPTOCOCCOSIS
隐球菌病中自然细胞介导的耐药性
- 批准号:
3480988 - 财政年份:1989
- 资助金额:
$ 21.24万 - 项目类别:
NATURAL CELL MEDIATED RESISTANCE IN CRYPTOCOCCOSIS
隐球菌病中天然细胞介导的耐药性
- 批准号:
2060804 - 财政年份:1989
- 资助金额:
$ 21.24万 - 项目类别:
相似海外基金
Interactions of Cryptococcus neoformans with mononuclear phagocytes in the brain
新型隐球菌与大脑中单核吞噬细胞的相互作用
- 批准号:
10667732 - 财政年份:2023
- 资助金额:
$ 21.24万 - 项目类别:
Leveraging genomic approaches to define sterol transport in Cryptococcus neoformans
利用基因组方法定义新型隐球菌中的甾醇转运
- 批准号:
10727128 - 财政年份:2023
- 资助金额:
$ 21.24万 - 项目类别:
The biology of Cryptococcus neoformans melanization
新型隐球菌黑化的生物学
- 批准号:
10660435 - 财政年份:2023
- 资助金额:
$ 21.24万 - 项目类别:
NK Cell Cytotoxicity Against Cryptococcus neoformans in Persons with Advanced HIV and Cryptococcal Meningitis
NK 细胞对晚期 HIV 和隐球菌性脑膜炎患者的新型隐球菌的细胞毒性
- 批准号:
10543405 - 财政年份:2022
- 资助金额:
$ 21.24万 - 项目类别:
Investigating the role of the kynurenine pathway on host and pathogen interactions in the fungal pathogen Cryptococcus neoformans.
研究犬尿氨酸途径对真菌病原体新型隐球菌宿主和病原体相互作用的作用。
- 批准号:
570115-2022 - 财政年份:2022
- 资助金额:
$ 21.24万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
CRISPR interference in Cryptococcus neoformans
CRISPR 干扰新型隐球菌
- 批准号:
571791-2022 - 财政年份:2022
- 资助金额:
$ 21.24万 - 项目类别:
University Undergraduate Student Research Awards
The role of septins in the adaptation of Cryptococcus neoformans to host temperature in HIV-based cryptococcosis
脓毒症在 HIV 隐球菌病中新型隐球菌适应宿主温度中的作用
- 批准号:
10619216 - 财政年份:2022
- 资助金额:
$ 21.24万 - 项目类别:
Overcoming fluconazole resistance in Cryptococcus neoformans.
克服新型隐球菌中的氟康唑耐药性。
- 批准号:
472967 - 财政年份:2022
- 资助金额:
$ 21.24万 - 项目类别:
Operating Grants
Role of phospholipids in antifungal drug resistance in Cryptococcus neoformans
磷脂在新型隐球菌抗真菌药物耐药性中的作用
- 批准号:
10654524 - 财政年份:2022
- 资助金额:
$ 21.24万 - 项目类别:
Impact of polyphosphate on host innate immune responses to Cryptococcus neoformans
聚磷酸盐对宿主对新型隐球菌先天免疫反应的影响
- 批准号:
476134 - 财政年份:2022
- 资助金额:
$ 21.24万 - 项目类别:
Studentship Programs














{{item.name}}会员




